Clinical Trial Update: A Multicenter, Randomized, Crossover Clinical Trial Study of Digital Intelligence Software in Patients With MAFLD [NA]

View source ↗

Summary

A multicenter, randomized, crossover trial is evaluating digital intelligence software in patients with metabolic dysfunction-associated fatty liver disease and…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Fatty Liver Disease

Snippet

Sponsor: The Affiliated Hospital of Hangzhou Normal University | Conditions: MAFLD | NA | Status: RECRUITING